Please login to the form below

Not currently logged in
Email:
Password:

flu vaccine

This page shows the latest flu vaccine news and features for those working in and with pharma, biotech and healthcare.

COVID-19 vaccines against Omicron may be fast-tracked

COVID-19 vaccines against Omicron may be fast-tracked

Regulators including the Food and Drug Administration (FDA) may treat Omicron-specific mRNA vaccines like seasonal flu vaccines, speeding up approval. ... BioNTech CEO Uğur Şahin has been talking about the similarities he sees between tweaked COVID-19

Latest news

More from news
Approximately 5 fully matching, plus 116 partially matching documents found.

Latest Intelligence

  • The new reality of building a corporate brand in pharma The new reality of building a corporate brand in pharma

    Has anyone ever paid attention to – or asked – who produced their annual flu vaccine? ... Unlikely. But as the COVID-19 vaccine has been rolled out, a common discussion between friends and families around the world is whether someone had been given

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    In England, the health system is working to provide a free flu vaccine to 30 million people, the highest number on record. ... A newly eligible group comprising 50- to 64-year-olds will also be offered a free flu vaccine later in the season.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    The company’s most advanced programme is a universal flu vaccine, VTP-100, which has just begun phase 2b trials.Vaccitech is also developing a clinical stage therapeutic vaccine for prostate ... We need new flu vaccine products that enable long-term

  • Country report: The healthcare market in Japan Country report: The healthcare market in Japan

    It launched a new division in January 2012 to expand its vaccines business globally, testing a new vaccine to prevent Haemophilus influenzae type b and developing a human papillomavirus vaccine and ... a flu vaccine.

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Health literacy in the time of COVID-19

    The most important determinants of COVID-19 vaccine hesitancy were distrust of the vaccine safety and general vaccine avoidance, as implied by not having had a flu shot in the last ... Likewise, a survey conducted in Portugal in late 2020 identified

  • What does the COVID-19 vaccine mean for the future of R&D?

    as genomics and molecular biology, that is supporting a new era in vaccine development. ... In 2009, the development of an H1N1 vaccine utilised existing flu vaccine technology.

  • Mistrust in medical research: a patient perspective

    The Thalidomide Society has said that comparisons between thalidomide and the COVID-19 vaccine are “insulting”. ... It’s worrying how many people still refuse the flu vaccine because they believe “it gives them the flu.”.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...